Synonyms:
Status: Phase 2
Entry Type: Protein
Molecule Category: Salt
UNII: FO8S2IW40N
Parent Compound: LARAZOTIDE

Structure

InChI Key NYGCNONRVCGHAT-UFIKZEAMSA-N
Smile CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C
InChI
InChI=1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C34H59N9O12
Molecular Weight 785.9
AlogP -3.18
Hydrogen Bond Acceptor 10.0
Hydrogen Bond Donor 9.0
Number of Rotational Bond 21.0
Polar Surface Area 301.32
Molecular species ACID
Aromatic Rings 0.0
Heavy Atoms 51.0

Pharmacology

Action Mechanism of Action Reference
PARTIAL AGONIST Neuronal acetylcholine receptor; alpha3/beta4 partial agonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Celiac Disease 2 D002446 ClinicalTrials

Related Entries

Parent

Cross References

Resources Reference
ChEMBL CHEMBL2103815
FDA SRS FO8S2IW40N
PubChem 44146842